David
Santamaría Velilla
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (5)
2024
-
In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma
Cell Reports Medicine, Vol. 5, Núm. 8
2021
-
Gene expression profiling as a potential tool for precision oncology in non-small cell lung cancer
Cancers, Vol. 13, Núm. 19
2016
-
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
Nature Medicine, Vol. 22, Núm. 3, pp. 270-277
-
KRAS-driven lung adenocarcinoma: Combined DDR1/Notch inhibition as an effective therapy
ESMO Open, Vol. 1, Núm. 5
2014
-
Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts
Cancer Research, Vol. 74, Núm. 21, pp. 5978-5988